Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Gene expression signature-based screening identifies new broadly effective influenza antivirals


ABSTRACT: Classical antiviral therapy inhibit viral proteins and are subject to resistance. To counteract this emergence, alternative strategy has been developed that target cellular factors. We hypothesized that such approach could also be useful to identify broad antivirals. Influenza A virus was used as a model for viral diversity and need for therapy against unpredictable viruses as recently underlined by the H1N1 pandemic. We proposed to identify a gene-expression signature associated with infection with different influenza A virus subtypes which could help to identify potential antiviral drugs with broad spectrum. Cellular gene expression response to infection with five different human and avian influenza viruses strains was analyzed and 300 genes were determined as differentially expressed between infected and non-infected samples. Strikingly, only a few genes were induced by infection and related to immune response. A more concise list was used to screen connectivity map, a database of drug-associated gene expression profiles, for molecules with inverse profiles than the signature of infection. We hypothesized that such compounds would induce an unfavorable cellular environment for influenza virus replication. Eight potential antivirals including ribavirin were identified, and six inhibited influenza viral growth in vitro. The new pandemic H1N1 virus, which was not used to define the gene expression signature of infection, was inhibited by five of the eight identified molecules, demonstrating that this strategy could help to identify broad spectrum antivirals. This is the first study showing that a gene expression based-screening can be used to identify antivirals. Such approaches could accelerate the drug discovery progress and could be extended to other pathogens. A549 (human lung epithelial cells) were infected with 5 different influenza A strains (A/New Caledonia/20/99 (H1N1), A/Moscow/10/99 (H3N2), A/Lyon/969/09 (H1N1 SOI-V), A/Turkey/582/2006 (H5N1), A/Finch/England/2051/94 (H5N2), and A/Chicken/Italy/2076/99 (H7N1)) or mock infected. Five independant replicates were done and hybridized on a different microarray. The overall design is thus composed of 5 mock samples, and 5x5 infected samples.

ORGANISM(S): Homo sapiens

SUBMITTER: Julien Textoris 

PROVIDER: E-GEOD-22319 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Gene expression signature-based screening identifies new broadly effective influenza a antivirals.

Josset Laurence L   Textoris Julien J   Loriod Béatrice B   Ferraris Olivier O   Moules Vincent V   Lina Bruno B   N'guyen Catherine C   Diaz Jean-Jacques JJ   Rosa-Calatrava Manuel M  

PloS one 20101004 10


Classical antiviral therapies target viral proteins and are consequently subject to resistance. To counteract this limitation, alternative strategies have been developed that target cellular factors. We hypothesized that such an approach could also be useful to identify broad-spectrum antivirals. The influenza A virus was used as a model for its viral diversity and because of the need to develop therapies against unpredictable viruses as recently underlined by the H1N1 pandemic. We proposed to i  ...[more]

Similar Datasets

2011-03-22 | GSE22319 | GEO
2010-05-15 | E-GEOD-9606 | biostudies-arrayexpress
2016-01-12 | E-GEOD-76719 | biostudies-arrayexpress
2012-09-13 | GSE40844 | GEO
2024-09-02 | BIOMD0000000529 | BioModels
2011-04-27 | E-GEOD-28871 | biostudies-arrayexpress
2013-04-17 | GSE46087 | GEO
2011-11-01 | E-GEOD-33351 | biostudies-arrayexpress
2013-07-31 | E-GEOD-47962 | biostudies-arrayexpress
2009-10-31 | E-GEOD-18816 | biostudies-arrayexpress